RPG Life Sciences Limited (RPGLIFE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs112.70 Million ≈ $1.22 Million USD) by net assets (Rs5.54 Billion ≈ $59.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See RPG Life Sciences Limited (RPGLIFE) net asset quality to measure how much of total assets are equity-financed.

RPG Life Sciences Limited - Cash Flow Conversion Efficiency Trend (2005–2026)

This chart illustrates how RPG Life Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check RPG Life Sciences Limited (RPGLIFE) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

RPG Life Sciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RPG Life Sciences Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ningbo Daye Garden Machinery Co Ltd SHE:300879	-0.191x
Aprogen KIC Inc KO:007460	-0.041x
Grid Dynamics Holdings Inc NASDAQ:GDYN	0.016x
DukSan Neolux Co.Ltd KQ:213420	0.043x
Kambi Group PLC ST:KAMBI	0.089x
Zhejiang Yilida Ventilator Co Ltd SHE:002686	0.038x
AGI Greenpac Limited NSE:AGI	-0.038x
Lycopodium Ltd AU:LYL	0.128x

Annual Cash Flow Conversion Efficiency for RPG Life Sciences Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of RPG Life Sciences Limited from 2005 to 2026. For the full company profile with market capitalisation and key ratios, see RPG Life Sciences Limited (RPGLIFE) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs6.05 Billion ≈ $65.47 Million	Rs652.80 Million ≈ $7.06 Million	0.108x	-26.52%
2025-03-31	Rs5.31 Billion ≈ $57.37 Million	Rs778.60 Million ≈ $8.42 Million	0.147x	-41.70%
2024-03-31	Rs3.75 Billion ≈ $40.54 Million	Rs943.60 Million ≈ $10.20 Million	0.252x	-14.74%
2023-03-31	Rs3.08 Billion ≈ $33.27 Million	Rs908.20 Million ≈ $9.82 Million	0.295x	+16.63%
2022-03-31	Rs2.56 Billion ≈ $27.66 Million	Rs647.50 Million ≈ $7.00 Million	0.253x	-5.96%
2021-03-31	Rs2.16 Billion ≈ $23.41 Million	Rs582.70 Million ≈ $6.30 Million	0.269x	-5.25%
2020-03-31	Rs1.77 Billion ≈ $19.10 Million	Rs501.70 Million ≈ $5.43 Million	0.284x	-0.38%
2019-03-31	Rs1.60 Billion ≈ $17.36 Million	Rs457.80 Million ≈ $4.95 Million	0.285x	+200.68%
2018-03-31	Rs1.55 Billion ≈ $16.74 Million	Rs146.80 Million ≈ $1.59 Million	0.095x	+93.85%
2017-03-31	Rs1.54 Billion ≈ $16.66 Million	Rs75.40 Million ≈ $815.42K	0.049x	-80.08%
2016-03-31	Rs1.34 Billion ≈ $14.45 Million	Rs328.10 Million ≈ $3.55 Million	0.246x	+1660.38%
2015-03-31	Rs1.25 Billion ≈ $13.54 Million	Rs-19.70 Million ≈ $-213.05K	-0.016x	+64.40%
2014-03-31	Rs1.26 Billion ≈ $13.60 Million	Rs-55.60 Million ≈ $-601.29K	-0.044x	-127.36%
2013-03-31	Rs762.30 Million ≈ $8.24 Million	Rs123.20 Million ≈ $1.33 Million	0.162x	-23.92%
2012-03-31	Rs741.40 Million ≈ $8.02 Million	Rs157.50 Million ≈ $1.70 Million	0.212x	+10.23%
2011-03-31	Rs748.31 Million ≈ $8.09 Million	Rs144.21 Million ≈ $1.56 Million	0.193x	-39.62%
2010-03-31	Rs644.31 Million ≈ $6.97 Million	Rs205.66 Million ≈ $2.22 Million	0.319x	-39.17%
2009-03-31	Rs549.21 Million ≈ $5.94 Million	Rs288.19 Million ≈ $3.12 Million	0.525x	-4.46%
2008-03-31	Rs492.02 Million ≈ $5.32 Million	Rs270.23 Million ≈ $2.92 Million	0.549x	+166.15%
2007-03-31	Rs742.36 Million ≈ $8.03 Million	Rs153.19 Million ≈ $1.66 Million	0.206x	+67.70%
2006-03-31	Rs667.72 Million ≈ $7.22 Million	Rs82.17 Million ≈ $888.59K	0.123x	-71.98%
2005-03-31	Rs150.60 Million ≈ $1.63 Million	Rs66.13 Million ≈ $715.16K	0.439x	--

About RPG Life Sciences Limited

NSE:RPGLIFE India Drug Manufacturers - Specialty & Generic

Market Cap

$493.09 Million

Rs45.59 Billion INR

Market Cap Rank

#12149 Global

#615 in India

Share Price

Rs2756.80

Change (1 day)

-0.41%

52-Week Range

Rs1744.00 - Rs3017.10

All Time High

Rs3017.10